Skip to main content

Table 2 CXCL16 and CXCR6 expression as predictors of disease-specific survival in 335 NSCLC patients

From: Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival

Characteristics Patients, N (%) Median survival (months) 5-year survival (%) P
CXCL16
 Cancer cells     .080
  High 48 (14) NR 67  
  Low 227 (68) 98 56  
  Missing 60 (18)    
 Stromal cells     .016
  High 258 (77) 189 62  
  Low 43 (13) 57 48  
  Missing 34 (10)    
CXCR6
 Cancer cells     .093
  High 41 (12) 190 73  
  Low 245 (73) 122 55  
  Missing 49 (15)    
CXCL16
 Cancer cells + stromal cells combined     .016
  High/High 43 (13) NR 71  
  High/Low 182 (54) 190 58  
  Low/Low 41 (12) 47 48  
  Missing 69 (21)    
  1. NR, not reached; NCSLC, non-small cell lung cancer. Bold values indicate p < 0.05